What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

Transplantation. 2008 Nov 15;86(9):1323-4. doi: 10.1097/TP.0b013e3181890788.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Case-Control Studies
  • Cytomegalovirus Infections / epidemiology*
  • Cytomegalovirus Infections / prevention & control*
  • Follow-Up Studies
  • Ganciclovir / analogs & derivatives*
  • Ganciclovir / therapeutic use
  • Humans
  • Incidence
  • Kidney Transplantation*
  • Opportunistic Infections / epidemiology
  • Opportunistic Infections / prevention & control
  • Valganciclovir

Substances

  • Antiviral Agents
  • Valganciclovir
  • Ganciclovir